We are live on ! Find out more
CNMD icon

CONMED
CNMD

252 hedge funds and large institutions have $4.3B invested in CONMED in 2021 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 95 increasing their positions, 78 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

80% more first-time investments, than exits

New positions opened: 36 | Existing positions closed: 20

22% more repeat investments, than reductions

Existing positions increased: 95 | Existing positions reduced: 78

6% more capital invested

Capital invested by funds: $4.05B → $4.3B (+$248M)

5% more funds holding

Funds holding: 239 → 252 (+13)

0.68% more ownership

Funds ownership: 107.28% → 107.96% (+0.68%)

93% less call options, than puts

Call options by funds: $1.95M | Put options by funds: $26.6M

Holders
252
Holders Change
+13
Holders Change %
+5.44%
% of All Funds
4.39%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
36
Increased
95
Reduced
78
Closed
20
Calls
$1.95M
Puts
$26.6M
Net Calls
-$24.6M
Net Calls Change
-$6.48M

Top Buyers

1
JP Morgan Chase
JP Morgan Chase
New York
+$59.8M
2
Aberdeen Group
Aberdeen Group
United Kingdom
+$37.2M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$28.5M
4
Victory Capital Management
Victory Capital Management
Texas
+$28M
5
Ameriprise
Ameriprise
Minnesota
+$19.4M

Top Sellers

1
CVA
Ceredex Value Advisors
Florida
-$42.5M
2
HM
HealthCor Management
New York
-$36.2M
3
CIP
Champlain Investment Partners
Vermont
-$31.3M
4
Millennium Management
Millennium Management
New York
-$25.3M
5
BlackRock
BlackRock
New York
-$16.6M
Name Holding Trade Value Shares
Change 		Change in
Stake
MF
251
Magnetar Financial
Illinois
$209 +$208K +1,518 New
BBHC
252
Brown Brothers Harriman & Co
New York
$34 – – –
CVA
253
Ceredex Value Advisors
Florida
– -$42.5M -325,046 Closed
HM
254
HealthCor Management
New York
– -$36.2M -276,940 Closed
Balyasny Asset Management
255
Balyasny Asset Management
Illinois
– -$16.1M -123,231 Closed
PVI
256
Pura Vida Investments
New York
– -$8.49M -65,000 Closed
CCM
257
Cinctive Capital Management
New York
– -$2.8M -21,434 Closed
MSL
258
Mackay Shields LLC
New York
– -$2.05M -15,700 Closed
D.E. Shaw & Co
259
D.E. Shaw & Co
New York
– -$970K -7,428 Closed
Walleye Capital
260
Walleye Capital
New York
– -$936 -7,169 Closed
WAM
261
Wolverine Asset Management
Illinois
– -$787K -6,030 Closed
SAM
262
Shell Asset Management
Netherlands
– -$691K -5,294 Closed
Los Angeles Capital Management
263
Los Angeles Capital Management
California
– -$582K -4,460 Closed
Lazard Asset Management
264
Lazard Asset Management
New York
– -$455K -3,485 Closed
Walleye Trading
265
Walleye Trading
New York
– -$401K -3,072 Closed
PP
266
Paloma Partners
Connecticut
– -$388K -2,968 Closed
BAM
267
Blueshift Asset Management
New Jersey
– -$346K -2,647 Closed
ONB
268
Old National Bancorp
Indiana
– -$272K -2,083 Closed
Cerity Partners
269
Cerity Partners
New York
– -$262K -2,010 Closed
CSS
270
Cubist Systematic Strategies
Connecticut
– -$218K -1,672 Closed
Federated Hermes
271
Federated Hermes
Pennsylvania
– -$152K -1,162 Closed
AAM
272
Advisors Asset Management
Colorado
– -$21K -160 Closed
7 8 9 10
11

CNMD Hedge Fund Activity: Q2 2021 in Review

252 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in CONMED (CNMD) for Q2 2021, worth a combined $4.3B — up 6.1% from $4.05B a quarter earlier.

Buyers outnumbered sellers: 36 funds opened new CNMD positions and 20 closed out — a net gain of 16 holders — while 95 added to existing stakes and 78 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $59.8M. The largest seller was Ceredex Value Advisors, exiting entirely with an estimated $42.5M sold.

  • 252 institutional investors held CONMED (CNMD) as of Q2 2021, up from 239 in Q1 2021.
  • Funds reported $4.3B of CONMED stock for Q2 2021, up 6.1% quarter-over-quarter.
  • 36 funds opened new CONMED positions in Q2 2021 and 20 closed out, a net change of +16 holders.
  • The largest CONMED buyer in Q2 2021 was JP Morgan Chase, an estimated $59.8M added.
  • The largest CONMED seller in Q2 2021 was Ceredex Value Advisors, an estimated $42.5M sold.

Based on aggregated 13F filings for Q2 2021.